Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics Simulations

Considering the current dramatic and fatal situation due to the high spreading of SARS-CoV-2 infection, there is an urgent unmet medical need to identify novel and effective approaches for prevention and treatment of Coronavirus disease (COVID 19) by re-evaluating and repurposing of known drugs. For...

Full description

Bibliographic Details
Main Authors: Rafat Zrieq, Iqrar Ahmad, Mejdi Snoussi, Emira Noumi, Marcello Iriti, Fahad D. Algahtani, Harun Patel, Mohd Saeed, Munazzah Tasleem, Shadi Sulaiman, Kaïss Aouadi, Adel Kadri
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/19/10693
_version_ 1797516267733647360
author Rafat Zrieq
Iqrar Ahmad
Mejdi Snoussi
Emira Noumi
Marcello Iriti
Fahad D. Algahtani
Harun Patel
Mohd Saeed
Munazzah Tasleem
Shadi Sulaiman
Kaïss Aouadi
Adel Kadri
author_facet Rafat Zrieq
Iqrar Ahmad
Mejdi Snoussi
Emira Noumi
Marcello Iriti
Fahad D. Algahtani
Harun Patel
Mohd Saeed
Munazzah Tasleem
Shadi Sulaiman
Kaïss Aouadi
Adel Kadri
author_sort Rafat Zrieq
collection DOAJ
description Considering the current dramatic and fatal situation due to the high spreading of SARS-CoV-2 infection, there is an urgent unmet medical need to identify novel and effective approaches for prevention and treatment of Coronavirus disease (COVID 19) by re-evaluating and repurposing of known drugs. For this, tomatidine and patchouli alcohol have been selected as potential drugs for combating the virus. The hit compounds were subsequently docked into the active site and molecular docking analyses revealed that both drugs can bind the active site of SARS-CoV-2 3CLpro, PLpro, NSP15, COX-2 and PLA2 targets with a number of important binding interactions. To further validate the interactions of promising compound tomatidine, Molecular dynamics study of 100 ns was carried out towards 3CLpro, NSP15 and COX-2. This indicated that the protein-ligand complex was stable throughout the simulation period, and minimal backbone fluctuations have ensued in the system. Post dynamic MM-GBSA analysis of molecular dynamics data showed promising mean binding free energy 47.4633 ± 9.28, 51.8064 ± 8.91 and 54.8918 ± 7.55 kcal/mol, respectively. Likewise, in silico ADMET studies of the selected ligands showed excellent pharmacokinetic properties with good absorption, bioavailability and devoid of toxicity. Therefore, patchouli alcohol and especially, tomatidine may provide prospect treatment options against SARS-CoV-2 infection by potentially inhibiting virus duplication though more research is guaranteed and secured.
first_indexed 2024-03-10T06:58:51Z
format Article
id doaj.art-64f56057593c408ea472210b0a2fef26
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T06:58:51Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-64f56057593c408ea472210b0a2fef262023-11-22T16:13:56ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-10-0122191069310.3390/ijms221910693Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics SimulationsRafat Zrieq0Iqrar Ahmad1Mejdi Snoussi2Emira Noumi3Marcello Iriti4Fahad D. Algahtani5Harun Patel6Mohd Saeed7Munazzah Tasleem8Shadi Sulaiman9Kaïss Aouadi10Adel Kadri11Department of Public Health, College of Public Health and Health Informatics, University of Ha’il, Ha’il 81451, Saudi ArabiaDivision of Computer Aided Drug Design, Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra 425405, IndiaDepartment of Biology, College of Science, University of Ha’il City, P.O. 2440, Ha’il 2440, Saudi ArabiaDepartment of Biology, College of Science, University of Ha’il City, P.O. 2440, Ha’il 2440, Saudi ArabiaDepartment of Agricultural and Environmental Sciences, Università degli Studi di Milano, 20133 Milano, ItalyDepartment of Public Health, College of Public Health and Health Informatics, University of Ha’il, Ha’il 81451, Saudi ArabiaDivision of Computer Aided Drug Design, Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra 425405, IndiaDepartment of Biology, College of Science, University of Ha’il City, P.O. 2440, Ha’il 2440, Saudi ArabiaSchool of Electronic Science and Engineering, University of Electronic Science and Technology of China, Chengdu 610054, ChinaDepartment of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, University of Ha’il, Ha’il 81451, Saudi ArabiaDepartment of Chemistry, College of Science, Qassim University, Buraidah 51452, Saudi ArabiaDepartment of Chemistry, Faculty of Science and Arts of Baljurashi, Albaha University, Al Bahah 65731, Saudi ArabiaConsidering the current dramatic and fatal situation due to the high spreading of SARS-CoV-2 infection, there is an urgent unmet medical need to identify novel and effective approaches for prevention and treatment of Coronavirus disease (COVID 19) by re-evaluating and repurposing of known drugs. For this, tomatidine and patchouli alcohol have been selected as potential drugs for combating the virus. The hit compounds were subsequently docked into the active site and molecular docking analyses revealed that both drugs can bind the active site of SARS-CoV-2 3CLpro, PLpro, NSP15, COX-2 and PLA2 targets with a number of important binding interactions. To further validate the interactions of promising compound tomatidine, Molecular dynamics study of 100 ns was carried out towards 3CLpro, NSP15 and COX-2. This indicated that the protein-ligand complex was stable throughout the simulation period, and minimal backbone fluctuations have ensued in the system. Post dynamic MM-GBSA analysis of molecular dynamics data showed promising mean binding free energy 47.4633 ± 9.28, 51.8064 ± 8.91 and 54.8918 ± 7.55 kcal/mol, respectively. Likewise, in silico ADMET studies of the selected ligands showed excellent pharmacokinetic properties with good absorption, bioavailability and devoid of toxicity. Therefore, patchouli alcohol and especially, tomatidine may provide prospect treatment options against SARS-CoV-2 infection by potentially inhibiting virus duplication though more research is guaranteed and secured.https://www.mdpi.com/1422-0067/22/19/10693tomatidinepatchouli alcoholCOVID-19drug repurposingdocking studydynamic simulation
spellingShingle Rafat Zrieq
Iqrar Ahmad
Mejdi Snoussi
Emira Noumi
Marcello Iriti
Fahad D. Algahtani
Harun Patel
Mohd Saeed
Munazzah Tasleem
Shadi Sulaiman
Kaïss Aouadi
Adel Kadri
Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics Simulations
International Journal of Molecular Sciences
tomatidine
patchouli alcohol
COVID-19
drug repurposing
docking study
dynamic simulation
title Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics Simulations
title_full Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics Simulations
title_fullStr Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics Simulations
title_full_unstemmed Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics Simulations
title_short Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics Simulations
title_sort tomatidine and patchouli alcohol as inhibitors of sars cov 2 enzymes 3clpro plpro and nsp15 by molecular docking and molecular dynamics simulations
topic tomatidine
patchouli alcohol
COVID-19
drug repurposing
docking study
dynamic simulation
url https://www.mdpi.com/1422-0067/22/19/10693
work_keys_str_mv AT rafatzrieq tomatidineandpatchoulialcoholasinhibitorsofsarscov2enzymes3clproplproandnsp15bymoleculardockingandmoleculardynamicssimulations
AT iqrarahmad tomatidineandpatchoulialcoholasinhibitorsofsarscov2enzymes3clproplproandnsp15bymoleculardockingandmoleculardynamicssimulations
AT mejdisnoussi tomatidineandpatchoulialcoholasinhibitorsofsarscov2enzymes3clproplproandnsp15bymoleculardockingandmoleculardynamicssimulations
AT emiranoumi tomatidineandpatchoulialcoholasinhibitorsofsarscov2enzymes3clproplproandnsp15bymoleculardockingandmoleculardynamicssimulations
AT marcelloiriti tomatidineandpatchoulialcoholasinhibitorsofsarscov2enzymes3clproplproandnsp15bymoleculardockingandmoleculardynamicssimulations
AT fahaddalgahtani tomatidineandpatchoulialcoholasinhibitorsofsarscov2enzymes3clproplproandnsp15bymoleculardockingandmoleculardynamicssimulations
AT harunpatel tomatidineandpatchoulialcoholasinhibitorsofsarscov2enzymes3clproplproandnsp15bymoleculardockingandmoleculardynamicssimulations
AT mohdsaeed tomatidineandpatchoulialcoholasinhibitorsofsarscov2enzymes3clproplproandnsp15bymoleculardockingandmoleculardynamicssimulations
AT munazzahtasleem tomatidineandpatchoulialcoholasinhibitorsofsarscov2enzymes3clproplproandnsp15bymoleculardockingandmoleculardynamicssimulations
AT shadisulaiman tomatidineandpatchoulialcoholasinhibitorsofsarscov2enzymes3clproplproandnsp15bymoleculardockingandmoleculardynamicssimulations
AT kaissaouadi tomatidineandpatchoulialcoholasinhibitorsofsarscov2enzymes3clproplproandnsp15bymoleculardockingandmoleculardynamicssimulations
AT adelkadri tomatidineandpatchoulialcoholasinhibitorsofsarscov2enzymes3clproplproandnsp15bymoleculardockingandmoleculardynamicssimulations